Hawkins (NASDAQ: HWKN) insider transactions
In the twelve months to 10 November 2026, executives and directors of Hawkins reported 0 open-market sales and 4 open-market purchases of 5,200 shares ($650,433), by 3 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 27 August 2026 | Oldenkamp Jeffrey P. | Executive VP and CFO | Open-market purchase | +1,290 | $119.00 | 104,223 | Form 4 |
| 25 August 2026 | Lange Douglas A. | VP - Water Treatment Group | Open-market purchase | +910 | $118.75 | 28,169 | Form 4 |
| 7 August 2026 | Hawkins Patrick H. | CEO and President | Gift | −580 | — | 321,257 | Form 4 |
| 29 July 2026 | Wright Jeffrey L | Director | Grant or award | +721 | — | 42,916 | Form 4 |
| 29 July 2026 | Thompson James T | Director | Grant or award | +721 | — | 38,916 | Form 4 |
| 29 July 2026 | Faulconbridge James A | Director | Grant or award | +721 | — | 53,128 | Form 4 |
| 29 July 2026 | Schumacher Mary J. | Director | Grant or award | +721 | — | 26,898 | Form 4 |
| 29 July 2026 | Stauber Daniel J | Director | Grant or award | +721 | — | 35,498 | Form 4 |
| 29 July 2026 | Spethmann Jeffrey E | Director | Grant or award | +721 | — | 6,639 | Form 4 |
| 29 July 2026 | Tang Yi | Director | Grant or award | +721 | — | 8,612 | Form 4 |
| 13 May 2026 | Hawkins Patrick H. | CEO and President | Grant or award | +16,934 | — | 321,726 | Form 4 |
| 13 May 2026 | Oldenkamp Jeffrey P. | Executive VP and CFO | Grant or award | +8,435 | — | 102,818 | Form 4 |
| 13 May 2026 | Grahek Drew M. | Vice President of Operations | Grant or award | +2,697 | — | 37,136 | Form 4 |
| 13 May 2026 | Rozeboom Shirley A. | VP Health and Nutrition | Grant or award | +1,906 | — | 34,088 | Form 4 |
| 13 May 2026 | Lange Douglas A. | VP - Water Treatment Group | Grant or award | +1,994 | — | 27,147 | Form 4 |
| 13 May 2026 | Mangine David J. | Vp-industrial Solutions Group | Grant or award | +1,906 | — | 27,763 | Form 4 |
| 13 May 2026 | Jones Gregory Alan | VP of Food and Health Sciences | Grant or award | +1,970 | — | 10,144 | Form 4 |
| 30 March 2026 | Rozeboom Shirley A. | VP Health and Nutrition | Shares withheld for tax | −3,608 | $151.62 | 31,959 | Form 4 |
| 30 March 2026 | Hawkins Patrick H. | CEO and President | Shares withheld for tax | −10,950 | $151.62 | 304,792 | Form 4 |
| 30 March 2026 | Oldenkamp Jeffrey P. | Executive VP and CFO | Shares withheld for tax | −5,675 | $151.62 | 94,383 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Hawkins page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.